Literature DB >> 15482469

Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis.

Bettina Sauer1, Rüdiger Vogler, Karsten Zimmermann, Makiko Fujii, Mario B Anzano, Monika Schäfer-Korting, Anita B Roberts, Burkhard Kleuser.   

Abstract

Lysophosphatidic acid (LPA, 1-acyl-glycerol-3-phosphate) plays an important role in diverse biological responses including cell proliferation, differentiation, survival, migration, and tumor cell invasion. The most prominent source of LPA is platelets from which it is released after thrombin activation and is assumed to be an essential function of this lysophospholipid in cutaneous wound closure. Therefore, we examined the role of LPA on biological responses of keratinocytes. Although LPA potently enhances keratinocyte migration, it strongly induces growth arrest of proliferating epidermal cells. Thus, LPA possesses analogous actions to transforming growth factor-beta (TGF-beta), which is also released from degranulating platelets at wounded sites. In contrast to LPA, the intracellular signaling events of TGF-beta have been clearly identified and indicate that Smad3 is involved in chemotaxis and cell growth arrest of keratinocytes induced by this cytokine. Here we show that LPA, although it does not alter TGF-beta release is capable to activate Smad3 and results in a heteromerization with Smad4 and binding of the complex to its specific DNA-promoter elements. LPA completely fails to induce chemotaxis in Smad3-deficient cells, whereas growth inhibition is at least in part reduced. These findings indicate an essential role of Smad3 in diverse biological properties of LPA-stimulated keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482469     DOI: 10.1111/j.0022-202X.2004.23458.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors:  Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

2.  Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts.

Authors:  Zhaohong Yin; Laura D Carbone; Mari Gotoh; Arnold Postlethwaite; Alyssa L Bolen; Gabor J Tigyi; Kimiko Murakami-Murofushi; Mitchell A Watsky
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

3.  Somatostatin inhibits cell migration and reduces cell counts of human keratinocytes and delays epidermal wound healing in an ex vivo wound model.

Authors:  Matthias Vockel; Simone Pollok; Ute Breitenbach; Ina Ridderbusch; Hans-Jürgen Kreienkamp; Johanna M Brandner
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

4.  Agonist-induced calcium entry correlates with STIM1 translocation.

Authors:  Kehinde Ross; Michael Whitaker; Nick J Reynolds
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

5.  Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.

Authors:  Hironobu Yamashita; Manisha Tripathi; Jerome Jourquin; Yoonseok Kam; Shanshan Liu; Brandy Weidow; Vito Quaranta
Journal:  J Oncol       Date:  2010-08-25       Impact factor: 4.375

6.  Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.

Authors:  Ling Nan; Jianxin Wei; Anastasia M Jacko; Miranda K Culley; Jing Zhao; Viswanathan Natarajan; Haichun Ma; Yutong Zhao
Journal:  Biochim Biophys Acta       Date:  2015-11-17

7.  Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.

Authors:  Christina H Stuelten; Rachel M Lee; Wolfgang Losert; Carole A Parent
Journal:  Cell Signal       Date:  2018-01-11       Impact factor: 4.315

8.  Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta.

Authors:  J Wu; A Mukherjee; D A Lebman; X Fang
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

Review 9.  Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.

Authors:  Chloé Rancoule; Sophie Espenel; Jane-Chloé Trone; Julien Langrand-Escure; Alexis Vallard; Amel Rehailia-Blanchard; Anis El Meddeb Hamrouni; Yaxiong Xia; Jean-Baptiste Guy; Majed Ben-Mrad; Nicolas Magné
Journal:  Oncotarget       Date:  2017-06-27

10.  Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation.

Authors:  Ralph Jans; Laura Mottram; Darren L Johnson; Anna M Brown; Stephen Sikkink; Kehinde Ross; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.